Park Medi World Limited (NSE:PARKHOSPS)

India · Delayed Price · Currency is INR

270.80

-4.15 (-1.51%)

At close: Oct 1, 2026

Market Cap	116.97B
Revenue (ttm)	17.56B +21.4%
Net Income	2.83B +34.9%
EPS	7.23 +28.9%
Shares Out	431.93M
PE Ratio	37.47
Forward PE	29.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	436,458
Open	272.30
Previous Close	274.95
Day's Range	268.50 - 274.20
52-Week Range	138.10 - 305.00
Beta	n/a
Analysts	Strong Buy
Price Target	362.50 (+33.86%)
Est. Earnings	Nov 3, 2026

About Park Medi World

Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paed... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2005

Employees 6,423

Stock Exchange National Stock Exchange of India

Ticker Symbol PARKHOSPS

Full Company Profile

Financial Performance

In fiscal year 2026, Park Medi World's revenue was 16.79 billion, an increase of 20.51% compared to the previous year's 13.94 billion. Earnings were 2.58 billion, an increase of 28.01%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for PARKHOSPS stock is "Strong Buy." The 12-month stock price target is ₹362.50, which is an increase of 33.86% from the latest price.

Price Target

₹362.50

(33.86% upside)

Analyst Consensus: Strong Buy

Stock Forecasts